Prognostic Value of Cardiopulmonary Exercise Test Parameters in Ventricular Assist Device Therapy

Ander Dorken Gallastegi1, Güneş D Ergi1, Ümit Kahraman1

  • 1From the Departments of Cardiovascular Surgery.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|September 8, 2021
PubMed

Insights

Cardiopulmonary exercise testing (CPET) before and after left ventricular assist device (LVAD) implantation predicts long-term survival. Postimplantation CPET offers valuable prognostic insights, especially when preimplantation data is unavailable.

Area of Science:

  • Cardiology
  • Exercise Physiology

Background:

  • Cardiopulmonary exercise test (CPET) parameters are established prognosticators in heart failure.
  • The prognostic utility of pre- and postimplantation CPET in left ventricular assist device (LVAD) therapy requires further elucidation.

Purpose of the Study:

  • To evaluate the prognostic value of preimplantation and postimplantation CPET parameters in patients undergoing LVAD therapy.
  • To assess the association between specific CPET metrics and postimplantation outcomes, including mortality.

Main Methods:

  • Retrospective analysis of adult patients who received an LVAD and underwent CPET pre- or postimplantation.
  • Calculation and multivariable analysis of five CPET parameters: vO2 max, oxygen uptake efficiency slope (OUES), VE/vCO2 Slope, VE/vCO2 min, and VE/vCO2 max.
  • Evaluation of the relationship between CPET parameters and 1, 3, and 5-year postimplantation outcomes.

Main Results:

  • Preimplantation vO2 max and OUES predicted 1, 3, and 5-year mortality; VE/vCO2 min predicted 3 and 5-year mortality; VE/vCO2 Slope predicted 5-year mortality.
  • Postimplantation vO2 max independently predicted 3 and 5-year mortality; VE/vCO2 max independently predicted 3-year mortality.
  • Preimplantation CPET parameters showed prognostic value for long-term survival, with weaker associations for early outcomes.

Conclusions:

  • Preimplantation CPET parameters are valuable for predicting long-term survival after LVAD implantation.
  • Postimplantation CPET parameters, specifically vO2 max and VE/vCO2 max, are associated with survival on device support and can aid prognostication when preimplantation data is absent.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
67
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
79
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
57